High-dose-rate brachytherapy in the curative treatment of patients with localized prostate cancer

Mayo Clin Proc. 2008 Dec;83(12):1364-72. doi: 10.1016/S0025-6196(11)60785-4.

Abstract

High-dose-rate brachytherapy is a relatively new radiotherapeutic intervention that is used as a curative treatment for patients with many types of cancer. Advances in mechanical systems and computer applications result in a sophisticated treatment technique that reliably delivers a high-quality radiation dose distribution to the intended target. Patients with localized prostate cancer may benefit from high-dose-rate brachytherapy, which may be used alone in certain circumstances or in combination with external-beam radiotherapy in other settings. The authors comprehensively searched the MEDLINE database for clinical studies published from January 1, 2002, through December 31, 2007, using the key terms brachytherapy, high-dose-rate, and prostatic neoplasms. Criteria for study review were study design, English language, relevance to clinicians, and validity based on design and appropriateness of conclusions. The abstract proceedings of meetings sponsored by the American Brachytherapy Society and the American Society for Therapeutic Radiology and Oncology were reviewed to identify additional relevant material. These sources provided the basis for a concise review of the rationale and advantages of high-dose-rate brachytherapy in the management of localized prostate cancer, as well as the details of the clinical use and therapeutic outcomes of this treatment as observed in a contemporaneous time frame.

Publication types

  • Review

MeSH terms

  • Brachytherapy / methods*
  • Dose Fractionation, Radiation*
  • Humans
  • Iridium Radioisotopes / therapeutic use
  • Male
  • Patient Selection
  • Prostatic Neoplasms / radiotherapy*
  • Radiotherapy Planning, Computer-Assisted
  • Treatment Outcome

Substances

  • Iridium Radioisotopes